HomeCompareNVIVQ vs KO

NVIVQ vs KO: Dividend Comparison 2026

NVIVQ yields 540.54% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIVQ wins by $112786.19M in total portfolio value
10 years
NVIVQ
NVIVQ
● Live price
540.54%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112786.22M
Annual income
$82,692,515,806.61
Full NVIVQ calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — NVIVQ vs KO

📍 NVIVQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVQKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIVQ + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVIVQ pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIVQ
Annual income on $10K today (after 15% tax)
$45,945.95/yr
After 10yr DRIP, annual income (after tax)
$70,288,638,435.62/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, NVIVQ beats the other by $70,288,634,777.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIVQ + KO for your $10,000?

NVIVQ: 50%KO: 50%
100% KO50/50100% NVIVQ
Portfolio after 10yr
$56393.13M
Annual income
$41,346,260,055.20/yr
Blended yield
73.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

NVIVQ
No analyst data
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIVQ buys
0
KO buys
0
No recent congressional trades found for NVIVQ or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVQKO
Forward yield540.54%2.70%
Annual dividend / share$2.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$112786.22M$34.1K
Annual income after 10y$82,692,515,806.61$4,303.79
Total dividends collected$110217.05M$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NVIVQ vs KO ($10,000, DRIP)

YearNVIVQ PortfolioNVIVQ Income/yrKO PortfolioKO Income/yrGap
1← crossover$64,754$54,054.05$10,846$335.73+$53.9KNVIVQ
2$396,410$327,123.28$11,829$430.64+$384.6KNVIVQ
3$2,295,726$1,871,567.31$12,988$555.50+$2.28MNVIVQ
4$12,586,137$10,129,710.14$14,372$721.34+$12.57MNVIVQ
5$65,369,349$51,902,182.37$16,049$944.01+$65.35MNVIVQ
6$321,877,325$251,932,121.38$18,114$1,246.74+$321.86MNVIVQ
7$1,503,762,535$1,159,353,797.14$20,702$1,664.24+$1503.74MNVIVQ
8$6,671,013,644$5,061,987,731.83$24,008$2,249.48+$6670.99MNVIVQ
9$28,124,961,234$20,986,976,635.20$28,317$3,085.19+$28124.93MNVIVQ
10$112,786,224,327$82,692,515,806.61$34,065$4,303.79+$112786.19MNVIVQ

NVIVQ vs KO: Complete Analysis 2026

NVIVQStock

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIVQ Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this NVIVQ vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIVQ vs SCHDNVIVQ vs JEPINVIVQ vs ONVIVQ vs MAINNVIVQ vs PEPNVIVQ vs PGNVIVQ vs JNJNVIVQ vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.